Pay for performance incentive reduces mortality in England

In this analysis of the impact of a pay for performance incentive program in England for pneumonia-AMI-CHF, overall mortality of those 3 diagnoses was reduced by 1.3% (eg 890 fewer deaths) in the 18 months after the program was implemented. The largest reduction in mortality was seen in pneumonia, followed by CHF and AMI. The England program incentives were larger, and the QI investments were more robust, compared to the US pay for performance program, which may account for the differences in outcomes (abstract).

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment